Antiretroviral drugs during breastfeeding for the prevention of postnatal transmission of HIV-1

Advances in Experimental Medicine and Biology

Volumn 743, Issue , 2012, Pages 173-183

  Kourtis, Athena P ^a   De Vincenzi, Isabelle ^b   Jamieson, Denise J ^a   Bulterys, Marc ^c,d,e  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; EFAVIRENZ PLUS EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; RITONAVIR; TENOFOVIR; ZIDOVUDINE;

ARTICLE; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CHILD HEALTH; CLINICAL EFFECTIVENESS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION PREVENTION; LACTATION; MATERNAL CARE; NEUTROPENIA; NONHUMAN; PERINATAL PERIOD; PRACTICE GUIDELINE; PRIORITY JOURNAL; RASH; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT PLANNING; VIRUS LOAD; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84859910293     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-2251-8_12     Document Type: Article

References (45)

1. UNAIDS. AIDS Epidemic Update: November 2009. http://data.unaids.org/pub/ Report/2009/jc1700-epi-update-2009-en.pdf . Nov 24 2009, Geneva, Switzerland. Accessed 14 Dec 2010
2. Horvath T, Madi BC, Iuppa IM, Kennedy GE, Rutherford G, Read JS (2009) Interventions for preventing late postnatal mother-to-child transmission of HIV. Cochrane Database Syst Rev CD006734
3. Nduati R, John G, Mbori-Ngacha D et al (2000) Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 283:1167-1174
4. World Health Organization (2010) HIV transmission through breastfeeding: a review of available evidence. http://www.unfpa.org/upload/lib-pub-fi le/276-filename-HIV-PREV-BF-GUIDE-ENG.pdf . Accessed 20 Nov 2010.
5. World Health Organization. Report of a WHO technical consultation on birth spacing. http://www.who.int/making pregnancy-safer/documents/birth- spacing.pdf . 15 Jun 2005. Accessed 20 Nov 2010
6. Jelliffe DB, Jelliffe EF (1978) Human milk in the modern world. Oxford University Press, New York
7. Achievements in public health (2006) Reduction in perinatal transmission of HIV infection - United States, 1985- 2005. MMWR Morb Mortal Wkly Rep 55:592-597
8. World Health Organization (2010) Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Recommendations for a public health approach. 2010 Version. http://www.who.int , Accessed: 15 Dec 2010.
9. Kuhn L, Aldrovandi GM, Sinkala M et al (2008) Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med 359:130-141
10. Kilewo C, Karlsson K, Ngarina M et al (2009) Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the Mitra Plus study. J Acquir Immune Defi c Syndr 52:406-416.10
11. Kumwenda NI, Hoover DR, Mofenson LM et al (2008) Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 359:119-12911
12. Palombi L, Marazzi MC, Voetberg A, Magid NA (2007) Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. AIDS 21(Suppl 4):S65-S711
13. Kesho Bora Study Group (2010) Eighteen month follow-up of HIV-1-infected mothers and their children enrolled in the Kesho Bora study observational cohorts. J Acquir Immune Defi c Syndr 54:533-541
14. Taha T, Kumwenda J, Cole S et al (2009) Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. J Infect Dis 200:1490-1497
15. Shapiro RL, Hughes M, Ogwu A et al (2010) Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med 362:2282-2294
16. Townsend CL, Cortina-Borja M, Peckham CS et al (2008) Low rates of mother to child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 22:973-981
17. Nduati R, Richardson BA, John G et al (2001) Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial. Lancet 26(357):1651-1655
18. Dabis F, Msellati P, Meda N et al (1999) 6-month effi cacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Cote dIvoire and Burkina Faso: a double- blind placebo-controlled multicentre trial. DITRAME Study Group. DIminution de la Transmission Mere- Enfant. Lancet 353:786-792
19. Guay LA, Musoke P, Fleming T et al (1999) Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 354:795-802
20. Connor EM, Sperling RS, Gelber R et al (1994) Reduction of maternal-infant transmission of human immunodefi - ciency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331:1173-1180
21. Cooper ER, Charurat M, Mofenson L et al (2002) Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defi c Syndr 29:484-494
22. Shaffer N, Chuachoowong R, Mock PA et al (1999) Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV Transmission Study Group. Lancet 353:773-780
23. Wiktor SZ, Ekpini E, Karon JM et al (1999) Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Cote dIvoire: a randomised trial. Lancet 353:781-785
24. Bedri A, Gudetta B, Isehak A et al (2008) Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 372:300-313
25. ThomasT, Masaba, R, Ndivo, R, Kisumu Breastfeeding Study Team (2008) Prevention of mother-to-child transmission of HIV-1 among breastfeeding mothers using HAART: The Kisumu Breastfeeding Study, Kisumu, Kenya, 2003-2007. Abstract 45aLB. In: 15th Conference on retroviruses and opportunistic infections, Boston, MA. http://www. retroconference.org/2008/Abstracts/33397.htm . Accessed 20 Apr 2010
26. The Kesho Bora study Group (2010) Triple-antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Lan Infect Dis 2011; 11:3: 171-180.
27. Chasela C, Hudgens M, Jamieson D et al (2010) Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 362:2271-2281
28. Giuliano M, Guidotti G, Andreotti M et al (2007) Triple antiretroviral prophylaxis administered during pregnancy and after delivery signifi cantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program. J Acquir Immune Defi c Syndr 44:286-291
29. Shapiro RL, Ndungú T, Lockman S et al. (2005) Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. J Infect Dis 192:713-719
30. Lehman DA, Chung MH, John-Stewart GC et al (2008) HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission. AIDS 22:1475-1485
31. Kilewo C, Karlsson K, Massawe A et al (2008) Prevention of mother-to-child transmission of HIV-1 through breastfeeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: the Mitra Study. J Acquir Immune Defi c Syndr 48:315-323
32. Bulterys M, Fowler MG, Van Rompay KK, Kourtis AP (2004) Prevention of mother-to-child transmission of HIV-1 through breast-feeding: past, present, and future. J Infect Dis 189:2149-2153
33. Palumbo P, Lindsey JC, Hughes MD et al (2010) Antiretroviral treatment failure for children with peripartum nevirapine exposure. N Engl J Med 363:1510-1520
34. Moorthy A, Gupta A, Bhosale R et al (2009) Nevirapine resistance and breast-milk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants. PLoS One 4:e4096
35. ClinicalTrials.gov (2010) Comparison of effi cacy and safety of infant peri-exposure prophylaxis with lopinavir/ritonavir versus lamivudine to prevent HIV-1 transmission by breastfeeding. http://clinicaltrials.gov/ct2/show/ NCT00640263 . Updated 8 Apr 2010. Accessed 10 Jan 2011
36. World Health Organization (2010) Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach. 2010 Revision. www.who.int . Accessed 10 Nov 2010.
37. Peltier CA, Ndayisaba GF, Lepage P et al (2009) Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda. AIDS 23:2415-2423
38. Zeh C, Weidle P, Nafi sa L, Musuluma H, Okonji J, Anyango E (2008) Emergence of HIV-1 drug resistance among breastfeeding infants born to HIV-infected mothers taking antiretrovirals for prevention of mother-to-child transmission of HIV: The Kisumu Breastfeeding Study, Kenya. In: 15th Conference on retroviruses and opportunistic infections. http://www.retroconference.org/ AbstractSearch/Default.aspx?Conf=19 . Accessed 20 Apr 2010
39. Mirochnick M, Thomas T, Capparelli E et al (2009) Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy. Antimicrob Agents Chemother 53:1170-1176
40. ClinicalTrials.gov (2010) Evaluating strategies to reduce mother-to-child transmission of HIV infection in resourcelimited countries (PROMISE). http://clinicaltrials.gov/ct2/show/NCT01061151 . Updated 14 Apr 2010. Accessed 30 Apr 2010
41. ClinicalTrials.gov (2009) Universal use of EFV-TDF-FTC and AZT-3TC-LPV/r combinations for HIV-1 PMTCT in pregnant and breastfeeding women: a phase 3 trial (UMA). http://clinicaltrials.gov/ct2/show/NCT00936195? term=UMA=1 . Updated 6 Aug 2009. Accessed 20 Jan 2011
42. World Health Organization (2010) Guidelines on HIV and infant feeding. Principles and recommendations for infant feeding in the context of HIV and a summary of evidence. www.who.int . Accessed 10 Nov 2010.
43. Kuhn L, Aldrovandi MG, Sinkala M et al (2010) Potential impact of new World Health Organization criteria for antiretroviral treatment for prevention of mother to child HIV transmission. AIDS 24:1374-1377
44. Thior I, Lockman S, Smeaton LM et al (2006) Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA 296:794-805
45. Bulterys M, Ellington S, Kourtis AP (2010) HIV-1 and breastfeeding: biology of transmission and advances in prevention. Clin Perinatol 37:807-824